Stock Screener: Medical , Medical-Drugs

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Drugs belongs to the sector Medical. This industry has a Market Cap of 313.27B. The top rated companies for Medical-Drugs industry are: Shire (SHPG) , Takeda Pharma (TKPYY) , Astellas Pharma (ALPMY).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
United Therapeutics (UTHR)
4.5/5 5.44B 7.98 -0.21% 1.15%
Taro Pharma (TARO)
4.4/5 4.74B 9.89 -1.42% -22.82%
SciClone Pharma (SCLN)
4.2/5 486.73M 16.29 -1.56% -29.48%
Sucampo Pharma (SCMP)
4.1/5 439.02M 23.05 -2.58% -17.97%
Jazz Pharma (JAZZ)
4.1/5 9.13B 24.22 -0.03% -2.75%
BioSpecifics Technologies (BSTC)
4.1/5 385.87M 34.53 3.12% 47.19%
USANA Health Sciences (USNA)
4.0/5 1.38B 14.64 1.35% -7.82%
Nutraceutical International (NUTR)
3.8/5 276.46M 14.88 -2.76% 21.2%
Zoetis (ZTS)
3.5/5 26.64B 32.84 1.29% 11.41%
Shire (SHPG)
3.5/5 51.89B 105.49 0.07% -7.13%
Corcept Therapeutics (CORT)
3.4/5 1.03B 130.14 -17.93% 76.89%
Lannett Co (LCI)
3.3/5 901.83M - -3.96% 19.05%
Grifols (GRFS)
3.1/5 13.62B 22.17 1.58% 25.55%
AVADEL PHARMA (AVDL)
3.0/5 385.65M - -1.38% -19.66%
Depomed (DEPO)
3.0/5 706.08M - -6.8% -35.18%
Catalent (CTLT)
2.9/5 3.5B 39.00 -0.04% -5.71%
Valeant Pharmaceuticals Intl Inc (VRX)
2.9/5 2.96B - -10.23% -76.35%
Xencor (XNCR)
2.8/5 1.09B 41.61 3.88% 65.25%
Nature's Sunshine Products (NATR)
2.7/5 188.64M 83.33 0.5% -4.76%
Endo International (ENDP)
2.7/5 2.29B - -4.19% -69.72%
Enanta Pharma (ENTA)
2.5/5 583.23M - -1.03% -3.62%
Ironwood Pharma (IRWD)
2.5/5 2.35B - 1.79% 46.68%
Pacira Pharma (PCRX)
2.5/5 1.7B - -1.09% -26.99%
Nektar Therapeutics (NKTR)
2.2/5 2.83B - -2.6% 13.26%
Fibrogen (FGEN)
2.2/5 1.81B - 2.36% 26.15%
Ionis Pharma (IONS)
2.1/5 5.48B - 4.98% 1.89%
AcelRx Pharma (ACRX) 2.1/5 115.61M - -7.27% -32.36%
Advanced Accelerator Applications (AAAP)
2.1/5 1.45B - -1.34% 7.51%
Egalet (EGLT) 2.1/5 106.89M - -3.64% -39.43%
Theravance Biopharma (TBPH)
2.1/5 2.05B - 3.03% 60.29%
Immune Design (IMDZ) 2.0/5 156.46M - 0.82% -63.06%
Foamix (FOMX)
2.0/5 153.88M - -0.96% -42.26%
Spectrum Pharma (SPPI)
2.0/5 570.35M - 10.61% -6.71%
Zogenix (ZGNX)
2.0/5 265.51M - 1.9% -8%
BioCryst Pharma (BCRX)
2.0/5 523.26M - -6.47% 88.7%
MediWound (MDWD) 2.0/5 145.83M - -4.32% -19.49%
Tesaro Inc (TSRO)
1.9/5 7.32B - -6.93% 195.1%
Aralez Pharma (ARLZ)
1.9/5 103.12M - -3.09% -62.8%
Aratana Therapeutics (PETX)
1.8/5 230.16M - 10.99% -14.68%
Durect (DRRX) 1.8/5 125.67M - 1.84% -35.8%
PTC Therapeutics (PTCT)
1.8/5 392.9M - 6.46% 36.99%
Ocular Therapeutix (OCUL)
1.8/5 250.9M - 1.93% -38.77%
Cempra (CEMP)
1.8/5 199.09M - 1.33% -80.21%
Portola Pharma (PTLA)
1.8/5 2.16B - 0.03% 49.75%
Achaogen (AKAO)
1.7/5 790.07M - 4.15% 469.07%
ImmunoGen (IMGN)
1.7/5 360.07M - 26.73% -56.57%
Bellicum (BLCM)
1.7/5 431.53M - -0.59% 16.7%
CTI BioPharma (CTIC) 1.6/5 110.36M - -3.22% -29.55%
Concert Pharma (CNCE)
1.6/5 350.57M - -4.96% 7.31%
Corbus Pharmaceuticals (CRBP)
1.5/5 325.94M - -5.8% 173.11%
Tetraphase Pharmaceuticals (TTPH)
1.5/5 299.79M - -1.22% 37.35%
Rigel Pharma (RIGL)
1.4/5 350.96M - -9.46% 2.5%
Neurocrine Biosciences (NBIX)
1.4/5 4.45B - -5.93% 5.01%
Aurinia (AUPH)
1.3/5 379.87M - 6.28% 137.79%
La Jolla Pharma (LJPC)
1.3/5 628.78M - 3.62% 43.16%
Karyopharm Therapeutics (KPTI)
1.3/5 473.9M - 0.27% 10.34%
ChemoCentryx (CCXI)
1.2/5 342M - -4.31% 161.03%
Heron Therapeutics (HRTX)
1.2/5 814.34M - 0.33% -34.37%
Ardelyx (ARDX)
1.1/5 591.6M - 2.88% 41.24%
MADRIGAL PHARMA (MDGL) 0.9/5 193.46M - 2.05% 22.9%
Esperion Therapeutics (ESPR) - 827.58M - -5.83% 90.1%
Aoxing Pharma (AXN) - 28.97M - -4.52% -49.33%
Sevion Therapeutics (SVON) - 3.55M - -18.57% -34.23%
Aeolus Pharma (AOLS) - 14.42M - -3.06% -46.02%
Nuvo Pharmaceuticals (NRIFF) - 43.9M 14.63 -5.19% -21.75%
Curaxis Pharma (CURXQ) - 0.05M - N/A N/A
Minerva Neurosciences (NERV) - 239.94M - -6.21% 6.25%
HST Global (HSTC) - 0.25M - 16.67% 40%
Enumeral Biomed (ENUM) - 12.84M - 0 -57.45
Merck KGAA (MKGAF) - 14.19B 30.59 -1.11% 22.9%
IntelGenx Technologies (IGXT) - 45.8M - 5.11% 35.85%
Tianyin Pharma (TPIY) - 0.29M - 100% -93.42%
Poniard Pharma (PARD) - 0.07M - 0 -58.33
Pharmaxis (PXSLY) - 63.82M - -16.67% 7.53%
Uluru (ULUR) - 4.58M - 20% -26.83%
TherapeuticsMD (TXMD) - 969.84M - -4.66% -41.69%
NanoViricides (NNVC) - 66.59M - -6.19% -49.52%
CSPC Pharma (CHPTY) - 7.58B 25.78 0 46.8
Bioasis Technologies (BIOAF) - 27.99M - 6.06% -44.27%
Dermira (DERM) - 1.32B - -4.49% 25.73%
INSPYR THERPTCS (NSPX) - 0.72M - -10.48% -87.48%
Integrated Biopharma (INBP) - 4.29M 2.99 -3.79% 105.05%
Symbollon Pharma (SYMBA) - 0M - N/A N/A
Novadel Pharma (NVDL) - 1.09M - 0 -27.27
Pacifichealth (PHLI) - 0.21M - -50% -50%
Vernalis (VNLPY) - 152.65M - 0 -58.27
Pharmagen (PHRX) - 0.93M - 100 0
Fennec Pharma (FENCF) - 49.61M - -5.19% 68.33%
Aerie Pharma (AERI) - 1.39B - -4.19% 148.79%
Alseres Pharma (ALSE) - 0.3M - 0 -23.08
GelStat (GSAC) - 0.17M - 0 -75
Ignyta (RXDX) - 352.36M - 1.2% 4.32%
China Sky One Medical (CSKI) - 1.02M - N/A N/A
Radius Health (RDUS) - 1.65B - 3.27% -1.42%
Otonomy (OTIC) - 373.67M - 0.41% -27.27%
Lotus Pharma (LTUS) - 0.1M - 0 -73.33
Neuroderm (NDRM) - 701.91M - 0.19% 45.55%
Skinvisible (SKVI) - 4.03M - 0 65
Tibet Pharma (TBET) - 0M - 0 0
Ono Pharma (OPHLF) - 294.62M 25.69 0 -98.84
SIGA Technologies (SIGA) - 282.03M - 10.84% 265.31%
Can-Fite Biopharma (CANF) - 30.01M - -1.63% -41.42%
Applied Neurosolutions (APSN) - 0M - N/A N/A
BIOCARDIA INC (BCDA) - 187.64M - -12.77% 393.98%
Acerus Pharma (TRLPF) - 18.75M 1.91 0 -38.89
CytoDyn (CYDY) - 83.7M - -20% -55.38%
Sage Therapeutics (SAGE) - 2.71B - 3.47% 85.86%
Imagenetix (IAGX) - 0.09M - -40% -91.67%
Meldex International (MLGGY) - 0.14M - N/A N/A
Cardax (CDXI) - 19.42M - 7.32% 300%
Pharmos (PARS) - 0.96M - -36% -40.74%
OXIS International (OXIS) - 1.93M - 0 -96.2
Puramed Bioscience (PMBS) - 0.02M - 0 0
Boston Therapeutics (BTHE) - 2.34M - -9.09% -24.24%
Akebia Therapeutics (AKBA) - 353.35M - 0.44% -6.09%
Generex Biotech (GNBT) - 6.76M - 11.94% -17.17%
Vertical Health (ONMDQ) - 0.16M - N/A N/A
China BCT (CNBI) - 0.47M - -7.69% 140%
Antriabio (ANTB) - 46.36M - -2.86% -0.97%
Elite Pharma (ELTP) - 133.65M 3.04 2.1% -55.21%
Kun Run Biotech (KURU) - 0.63M - 0 0
Forward Pharma (FWP) - 920.09M - -1.56% -11.76%
Indivior (INVVY) - 2.98B 83.00 2.72% 71.49%
Synovics Pharma (SYVC) - 0M - 0 0
Osteologix (OLGXF) - 0.2M - 0 -14.29
Pharmathene (PIP) - 52.64M 0.26 -2.3% -68.65%
Synergy Pharma (SGYP) - 917.01M - -7.01% 9.89%
Vioquest Pharma (VOQP) - 0.04M - 0 60
AXM Pharma (AXMP) - 0.06M - 0 -25
Ampio Pharma (AMPE) - 32.3M - -7.54% -86.11%
Flexion Therapeutics (FLXN) - 836.77M - -5.89% 106.66%
Health Sciences Group (HESG) - 0.19M - 0 0
Actinium Pharma (ATNM) - 86.5M - 0.65% -24.02%
Eisai (ESALY) - 15.61B 30.26 1.25% -20.92%
Medicure (MCUJF) - 97.8M 29.91 -0.05% 33.62%
Neurobio Tech (NTII) - 0.38M - 0 0
Shandong Luoxin (SLUXY) - 223.97M - 0 -1.16
Takeda Pharma (TKPYY) - 38.4B 30.36 1.27% -2.57%
Ore Holdings (ORXE) - 0.66M - 0 33.33
Pivotal Therapeutics (PVTTF) - 0.1M - -50% -90%
UCB SA (UCBJF) - 15.06B - 0 -1.21
Protalex (PRTX) - 28.77M - -9.91% -75.31%
Bohai Pharma (BOPH) - 8.79M - 12.5% 11.11%
Evotec (EVTCY) - 1.64B 48.78 1.91% 185.68%
Innate Pharma (IPHYF) - 606.55M - -2.77% -23.68%
American Oriental Bioengineering (AOBI) - 0.37M - 0 66.67
Inyx (IYXI) - 0.16M - 0 0
Matinas Biopharma (MTNB) - 260.93M - -0.68% 365.08%
Miravant Medical Technologies (MRVT) - 0M - N/A N/A
Innovus Pharma (INNV) - 14.88M - -2.94% -1%
Immunosyn Corp. (IMYN) - 0.03M - N/A N/A
Rock Creek Pharma (RCPIQ) - 0.24M - -50% -99.47%
Futurebiotics (VITK) - 0M - 0 0
Tribute Pharma (TBUFF) - 117.37M - N/A N/A
Acusphere (ACUS) - 0.15M - 0 -9.09
Astellas Pharma (ALPMY) - 30.05B 15.33 -0.29% -1.76%
Redhill Biopharma (RDHL) - 177.06M - 5.06% -21.6%
Emisphere Tech (EMIS) - 28.54M - -2.08% -28.24%
Loxo Oncology (LOXO) - 1.25B - 3.89% 87.41%
NovaBay Pharma (NBY) - 51.01M - -8.58% 71.13%
Peak Pharma (PKPH) - 4.7M - -7.69% 50%
IsoRay (ISR) - 30.7M - -2.28% -49.27%
Omni Bio Pharmaceuticals (OMBP) - 1.1M - 29.41% -26.67%
Polydex Pharma (POLXF) - 4.9M 6.91 3.57% -22.04%